.0<4,9>.0<13,18>]nonadeca-2(10),4,6,8-tetraene;HSIBGVUMFOSJPD-NXWOVTFFSA-N;10-Methoxyibogamine;C09214;BDBM50206577;SCHEMBL21333266;6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine deriv.;(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene;IBOGAINE (MART.);(1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene;12 Methoxyibogamine;HSIBGVUMFOSJPD-CFDPKNGZSA-N;6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole, ibogamine deriv.;GTPL13148;DTXCID401324112;(1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene">
Ibogaine

CAS No.:83-74-9

TBW04909
Ibogamine, 12-methoxy-;Ibogaine;12-methoxy-ibogamin;12-Methoxyibogamine;endabuse;Ibogain;Ibogamine,12-methoxy;[ "" ];Tabernanthe iboga;(-)-Ibogaine;NIH 10567;DEA No. 7260;3S814I130U;C20H28N2O;HJM;Ibogaine (8CI);Q409455;12-Methoxyibogamine (ACI);6,9-Methano-5H-pyrido[1′,2′:1,2]azepino[4,5-b]indole, ibogamine deriv. (ZCI);Ibogaine (7CI, 8CI);MeSH ID: D007050;NSC 249764;SCHEMBL14964144;IBOGAINE [MART.];7-Ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido(1',2':1,2)azepino(5,4-b)indole;NSC-249764;BDBM50308247;IBOGAINE [VANDF];IBOGAINE [MI];IBOGAINE [WHO-DD];CHEMBL1215855;CHEBI:5852;NS00041096;EINECS 201-498-4;FS-9083;(5beta)-12-methoxyibogamine;(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene;UNII-3S814I130U;HSDB 8180;SCHEMBL113571;83-74-9;(18R)-12-methoxyibogamine;DTXSID20894069;NCGC00247731-01;17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene;NIH-10567;NSC628053;12-Methoxyibogamine hydrochloride;SCHEMBL14664380;DTXSID70860532;HSIBGVUMFOSJPD-UHFFFAOYSA-N;12-Methoxyibogamine #;AC1L9C9B;CHEBI:471972;AKOS032948157;CHEMBL222287;3,13-Diaza-17-ethyl-7-methoxypentacyclo[13.3.1.0<2,10>.0<4,9>.0<13,18>]nonadeca-2(10),4,6,8-tetraene;HSIBGVUMFOSJPD-NXWOVTFFSA-N;10-Methoxyibogamine;C09214;BDBM50206577;SCHEMBL21333266;6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine deriv.;(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene;IBOGAINE (MART.);(1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene;12 Methoxyibogamine;HSIBGVUMFOSJPD-CFDPKNGZSA-N;6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole, ibogamine deriv.;GTPL13148;DTXCID401324112;(1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene
inquiry
C20H26N2O
310.43

Product introduction

Category: Natural products
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: C([C@H]1CC2C[C@H]3C4NC5C=CC(=CC=5C=4CC[N@@]([C@@H]13)C2)OC)C